Medicare Enrolled

Dr. Paul Denker, MD

Endocrinology · Palm Harbor, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
32615 US HIGHWAY 19 N STE 2, Palm Harbor, FL 34684
7277892784
In practice since 2006 (19 years)
NPI: 1750328811 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Denker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Denker? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Denker

Dr. Paul Denker is an endocrinology in Palm Harbor, FL, with 19 years in practice. Based on federal Medicare data, Dr. Denker performed 607 Medicare services across 428 unique beneficiaries.

Between the years covered by Open Payments, Dr. Denker received a total of $18,465 from 64 pharmaceutical and/or device companies across 922 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Denker is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 607 Medicare services$ $18,465 industry payments

Medicare Practice Summary

Medicare Utilization ↗
607
Medicare services
Bottom 45% in FL for endocrinology
428
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)325$122$437
Office visit, established patient (30-39 min)268$91$311
Hemoglobin A1c test (diabetes monitoring)14$10$25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,465
Total received (2018-2024)
Avg $2,638/year across 7 years
Top 19% in FL for endocrinology
64
Companies
922
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,465 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,624
2023
$3,525
2022
$3,008
2021
$2,722
2020
$1,635
2019
$2,612
2018
$3,337

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$3,213
AstraZeneca Pharmaceuticals LP
$1,761
SANOFI-AVENTIS U.S. LLC
$1,624
Lilly USA, LLC
$1,561
Amgen Inc.
$988
Boehringer Ingelheim Pharmaceuticals, Inc.
$857
Abbott Laboratories
$685
Xeris Pharmaceuticals, Inc.
$611
IBSA Pharma Inc.
$521
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$504
Dexcom, Inc.
$456
Insulet Corporation
$380
Corcept Therapeutics
$380
Astellas Pharma US Inc
$355
Amneal Pharmaceuticals LLC
$283
Amarin Pharma Inc.
$278
Antares Pharma, Inc.
$249
Mannkind Corporation
$237
MannKind Corporation
$194
LIFESCAN, INC.
$189
Bayer Healthcare Pharmaceuticals Inc.
$171
Zealand Pharma US, Inc.
$148
Merck Sharp & Dohme Corporation
$146
Bayer HealthCare Pharmaceuticals Inc.
$145
Janssen Pharmaceuticals, Inc
$144
Alexion Pharmaceuticals, Inc.
$142
Nevro Corp.
$140
Ultragenyx Pharmaceutical Inc.
$137
GRT US Holding, Inc.
$133
Valeritas, Inc.
$132
AbbVie, Inc.
$124
Radius Health, Inc.
$119
PFIZER INC.
$113
UCB, Inc.
$105
DEXCOM, INC.
$92
BETA BIONICS, INC.
$91
Novartis Pharmaceuticals Corporation
$69
Supernus Pharmaceuticals, Inc.
$68
RECORDATI_RARE_DISEASES_INC.
$67
Ipsen Biopharmaceuticals, Inc
$62
Embecta Corp.
$57
Horizon Therapeutics plc
$55
Otsuka America Pharmaceutical, Inc.
$50
Acerus Pharmaceuticals Corporation
$50
Tandem Diabetes Care, Inc.
$46
Merck Sharp & Dohme LLC
$45
Medtronic, Inc.
$44
CeQur Corporation
$40
Merz Pharmaceuticals, LLC
$38
Shire North American Group Inc
$37
Regeneron Healthcare Solutions, Inc.
$36
Medtronic MiniMed, Inc.
$34
Esperion Therapeutics, Inc.
$32
Aurinia Pharma U.S., Inc.
$30
Currax Pharmaceuticals LLC
$29
AbbVie Inc.
$26
Kyowa Kirin, Inc.
$21
Aytu BioScience, Inc
$20
VIVUS LLC
$20
ABBVIE INC.
$19
Avvisto Therapeutics, LLC
$18
Ferring Pharmaceuticals Inc.
$18
KVK-Tech, Inc.
$14
Strongbridge US INC.
$13
Top 3 companies account for 35.7% of total payments
Associated products mentioned in payments ›
ADMELOG · AFREZZA · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BYDUREON · Bimzelx · CONTRAVE · CRYSVITA · CYCLOSET · CeQur Simplicity · Cimzia · Creon · Crysvita · Cryvista · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVKEEZA · Enbrel · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKAMET · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LUPKYNIS · Levemir · MACRILEN · MOUNJARO · MYRBETRIQ · Minimed 670G System · Minimed 770G System · NATPARA · NEXLETOL · NOCDURNA · Natesto · OFEV · ONETOUCH VERIO FLEX · Omnia · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · Ponvory · Prolia · QSYMIA · Qutenza · REXULTI · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · STRENSIQ · SYMBICORT · SYNTHROID · Saxenda · Senza · Somatuline Depot · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · VESICARE · Vascepa · Victoza · Wegovy · XIFAXAN · XYOSTED · Xeomin · ZEGALOGUE · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,042 per 100 Medicare services performed
Looking for a endocrinology in Palm Harbor?
Compare endocrinologys in the Palm Harbor area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
76
Per 100K population
7.9
County median income
$70,293
Nearest hospital
MEASE DUNEDIN HOSPITAL
5.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Denker is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 19%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Denker experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Denker performed 325 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Denker receive payments from pharmaceutical companies?
Yes. Dr. Denker received a total of $18,465 from 64 companies across 922 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Denker's costs compare to other endocrinologys in Palm Harbor?
Dr. Denker's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Denker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →